Evidence map›Paper›PMID 24352472›Full record

ArticleJournal of virology2014

Hepatitis C virus stimulates low-density lipoprotein receptor expression to facilitate viral propagation.

Gulam Hussain Syed, Huihui Tang, Mohsin Khan, Tarek Hassanein, Jingwen Liu, Aleem Siddiqui

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 3 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 3 syntheses or guidelines pooled it, 106 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Gulam Hussain SyedDepartment of Medicine, Division of Infectious Diseases, University of California, San Diego, La Jolla, California, USA.
Huihui Tang
Mohsin Khan
Tarek Hassanein
Jingwen Liu
Aleem Siddiqui
University of California, San Diego · USSouthern California Reproductive Center · USVA Palo Alto Health Care System · US

Funding

Viral Hepatitis C and Lipid HomeostasisR01DK077704 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SIDDIQUI, ALEEM · 2008 to 2017
$3.0M
Role of Lipids in Hepatitis C Virus MaturationR01AI085087 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SIDDIQUI, ALEEM · 2010 to 2018
$2.9M
Targeting PCSK9 Transcription to Combat Hypercholesterolemia by BerberineR01AT006336 · NCCIH · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI LIU, JINGWEN · 2012 to 2016
$1.7M
Role of Lipids in Hepatitis C Virus MaturationR56AI085087 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SIDDIQUI, ALEEM · 2014 to 2014
$388k
NCCIH NIH HHS R01 AT006336NIAID NIH HHS AI085087NIAID NIH HHS R01 AI085087NIAID NIH HHS R56 AI085087NIDDK NIH HHS DK077704NIDDK NIH HHS DK08379NIDDK NIH HHS R01 DK077704
6 · The paper itself

Abstract

unlabelledLipids play a crucial role in multiple aspects of hepatitis C virus (HCV) life cycle. HCV modulates host lipid metabolism to enrich the intracellular milieu with lipids to facilitate its proliferation. However, very little is known about the influence of HCV on lipid uptake from bloodstream. Low-density lipoprotein receptor (LDLR) is involved in uptake of cholesterol rich low-density lipoprotein (LDL) particles from the bloodstream. The association of HCV particles with lipoproteins implicates their role in HCV entry; however, the precise role of LDLR in HCV entry still remains controversial. Here, we investigate the effect of HCV infection on LDLR expression and the underlying mechanism(s) involved. We demonstrate that HCV stimulates LDLR expression in both HCV-infected Huh7 cells and in liver tissue from chronic hepatitis C patients. Fluorescence activated cell sorting and immunofluorescence analysis revealed enhanced cell surface and total expression of LDLR in HCV-infected cells. Increased LDLR expression resulted in the enhanced uptake of lipoprotein particles by HCV-infected cells. Analysis of LDLR gene promoter identified a pivotal role of sterol-regulatory element binding proteins (SREBPs), in the HCV-mediated stimulation of LDLR transcription. In addition, HCV negatively modulated the expression of proprotein convertase subtilisin/kexin type 9 (PCSK9), a protein that facilitates LDLR degradation. Ectopic expression of wild-type PCSK9 or gain-of-function PCSK9 mutant negatively affected HCV replication. Overall, our results demonstrate that HCV regulates LDLR expression at transcriptional and posttranslational level via SREBPs and PCSK9 to promote lipid uptake and facilitate viral proliferation. IMPORTANCE: HCV modulates host lipid metabolism to promote enrichment of lipids in intracellular environment, which are essential in multiple aspects of HCV life cycle. However, very little is known about the influence of HCV on lipid uptake from the bloodstream. LDLR is involved in uptake of cholesterol rich lipid particles from bloodstream. In this study, we investigated the effect of HCV on LDLR expression and the underlying mechanism triggered by the virus to modulate LDLR expression. Our observations suggest that HCV upregulates LDLR expression at both the protein and the transcript levels and that this upregulation likely contributes toward the uptake of serum lipids by infected hepatocytes. Abrogation of HCV-mediated upregulation of LDLR inhibits serum lipid uptake and thereby perturbs HCV replication. Overall, our findings highlight the importance of serum lipid uptake by infected hepatocytes in HCV life cycle.

Indexed as

Gene ExpressionVirus ReplicationBinding SitesCell LineConsensus SequenceGene Expression RegulationHepacivirusHepatitis CHumansLipoproteins, LDLMutationPromoter Regions, GeneticProprotein Convertase 9Proprotein ConvertasesReceptors, LDLSerine EndopeptidasesLipoproteins, LDLPCSK9 protein, humanProprotein Convertase 9Proprotein ConvertasesReceptors, LDLSerine EndopeptidasesSterol Regulatory Element Binding Proteins

Identifiers

PMID24352472
PMCPMC3958050
OpenAlexW2016981683

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.